Dietary Antioxidant Anthocyanins Mitigate Type II Diabetes through Improving the Disorder of Glycometabolism and Insulin Resistance

J Agric Food Chem. 2021 Nov 17;69(45):13350-13363. doi: 10.1021/acs.jafc.1c05630. Epub 2021 Nov 3.

Abstract

Insulin resistance (IR) is one of the pathological reasons for type II diabetes mellitus (T2DM). Therefore, it is important to prevent the body from developing T2DM by improving IR and maintaining glucose homeostasis. Anthocyanins (ACNs) are water-soluble pigments and are widely distributed in natural products. This article summarizes research on the bioavailability and metabolism of ACNs. Moreover, we further elaborate on how ACNs reduce IR and hyperglycemia during the development of T2DM based on studies over the past 20 years. Many studies have demonstrated that ACNs are small molecules that target the pancreatic, liver, muscle, and adipose tissues, preventing IR and hyperglycemia. However, the molecular mechanisms are still unclear. Therefore, we envision whether the molecular mechanism of reducing T2DM by ACNs could be more deeply investigated.

Keywords: ACN; IR; T2DM; hyperglycemia.

MeSH terms

  • Anthocyanins
  • Antioxidants / pharmacology
  • Blood Glucose
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diet
  • Humans
  • Insulin
  • Insulin Resistance*

Substances

  • Anthocyanins
  • Antioxidants
  • Blood Glucose
  • Insulin